SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001839882-23-009536
Filing Date
2023-04-13
Accepted
2023-04-13 16:45:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS admp-defa14a_040323.htm DEFA14A 39863
2 GRAPHIC admp-defa14a_img1.jpg GRAPHIC 156257
  Complete submission text file 0001839882-23-009536.txt   256307
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36242 | Film No.: 23818882
SIC: 2834 Pharmaceutical Preparations